Hannelore Ehrenreich

from Wikipedia, the free encyclopedia

Hannelore Ehrenreich (* 2. April 1955 in Augsburg ) is a German veterinarian and physician specializing in neurology and psychiatry .

Live and act

Hannelore Ehrenreich studied medicine and veterinary medicine in Hanover and Munich . In Munich it was in 1981 with the work of endogenous opiates importance in the context of reproductive events for Dr. med. vet. and in 1989 with the work Endocrine Effects of Human Corticotropin-Releasing Factor in Healthy and Diabetics. Modulation through opioid receptor blockade to Dr. med. PhD . She then completed several stays abroad, some of which were financed with scholarships, in the USA, England and the Philippines. In 1993 she completed her habilitation with her thesis on the pathophysiology of the endotheline, potent vasoactive and mitogenic cytokines in the central nervous system .

Hannelore Ehrenreich has been Professor of Neurology and Psychiatry since 1998 and heads the Clinical Neurosciences Working Group at the Max Planck Institute for Experimental Medicine in Göttingen . She also worked as a senior physician in the clinics for neurology and psychiatry at the Göttingen University Hospital . From 2000 to 2002 she was Vice President of the Georg-August University in Göttingen , and since 2003 she has been a member of the University Council of the Hannover Medical School. In the summer of 2004, she was offered a chair in neurology at the Medical University of Graz .

Since 2007 she has been a member of the board of trustees of the Felix Wankel Foundation of the International Society for Farming Animal Husbandry . She has been a member of the Neuroscience Section of the Leopoldina since 2016 .

Hannelore Ehrenreich was first known for her work on alcoholism therapy. Today she researches primarily in the sense of translational medicine for neuroprotection in neuropsychiatric diseases. The focus is on schizophrenia and autism ; This work ranges from molecular-cellular characterization through genotype - phenotype associations of human and animal behavior to clinical studies . Another focus is the neuroprotective and cognitive effects of erythropoietin in human brain diseases.

Awards

Fonts

Hannelore Ehrenreich is the author or co-author of over 240 publications in specialist journals.

German language fonts

  • Significance of endogenous opiates in the context of reproductive processes. Dissertation. Veterinary Faculty of the University of Munich, 1981. Enke, Stuttgart 1981, ISBN 3-432-92471-2 .
  • Endocrine effects of human corticotropin-releasing factor in healthy individuals and diabetics. Modulation by opioid receptor blockade. Medical dissertation. University of Munich, 1989.
  • On the pathophysiology of the endotheline, potent vasoactive and mitogenic cytokines, in the central nervous system. Habilitation thesis. University of Göttingen, 1993.
  • Contribution in Norbert Elsner , Hans-Ludwig Schreiber (Ed.): What is man? Wallstein, Göttingen 2002, ISBN 3-89244-604-0 .
  • with Anna-Leena Sirén : EPO. Neuroprotection in brain diseases. In: Georgia Augusta. Volume 2. University of Göttingen, 2003, ISSN  0016-8157 , pp. 111-115. ( online , PDF; 225 kB)
  • with Henning Krampe: Therapy for alcohol addiction. In: P. Schauder and G. Ollenschläger (eds.): Nutritional medicine. 3. Edition. Elsevier, Urban & Fischer, Munich 2006, ISBN 3-437-22921-4 .

Web links

Individual evidence

  1. Members of the University Council of the MHH , accessed on November 10, 2009
  2. Names and Messages. In: uni | in | form of the Georg-August-Universität Göttingen. No. 2/2004, August 2004, p. 20, accessed on November 10, 2009
  3. Member entry by Prof. Dr. Dr. Hannelore Ehrenreich (with picture and CV) at the German Academy of Natural Scientists Leopoldina , accessed on January 4, 2017.
  4. Brief therapy alone is of little use in the case of alcohol addiction , press release of the Max Planck Society of May 15, 2003.
  5. Hannelore Ehrenreich, Martin Hasselblatt, Christoph Dembowski, Lukas Cepek, Piotr Lewczuk: Erythropoietin therapy for acute stroke is both safe and beneficial . In: Molecular Medicine (Cambridge, Mass.) . tape 8 , no. 8 , August 1, 2002, ISSN  1076-1551 , p. 495-505 , PMID 12435860 .
  6. H. Ehrenreich, D. Hinze-Selch, S. Stawicki, C. Aust, S. Knolle-Veentjer: Improvement of cognitive functions in chronic schizophrenic patients by recombinant human erythropoietin . In: Molecular Psychiatry . tape 12 , no. 2 , February 1, 2007, ISSN  1359-4184 , p. 206-220 , doi : 10.1038 / sj.mp.4001907 .
  7. The previous Wilhelm Feuerlein Prize winners on the Oberberg Foundation website
  8. Publications on ncbi.nlm.nih.gov
  9. ^ Announcement from the publisher with list of authors